A multicenter, randomized, double-blind, placebo-controlled phase 3 study of Socazolimab or placebo combined with carboplatin and etoposide in the first-line treatment of extensive-stage small cell lung cancer
一项多中心、随机、双盲、安慰剂对照的3期临床研究，旨在评估索卡唑利单抗或安慰剂联合卡铂和依托泊苷一线治疗广泛期小细胞肺癌的疗效。
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-024-02115-5
Chen, Zhiwei; Chen, Jianhua; Huang, Dingzhi; Zhang, Wei; Wu, Lin; Yi, Tienan; Wang, Qiming; Han, Liang; Tan, Liping; Li, Yinyin; Zhang, Zhihong; Li, Na; Li, Jie; Zhang, Tongmei; Hu, Ying; Sun, Hongmei; Wu, Youhua; He, Zhiyong; Yang, Runxiang; Cheng, Peng; Li, Xingya; Shi, Jianhua; Yu, Guohua; Ma, Daiyuan; Li, Benjamin Xiaoyi; Dai, Xiangrong; Wong, Michael; Li, Yujie; Yu, Xiaohui; Lu, Shun
